|Mir-34: a new weapon against cancer?|
G Misso, MT Di Martino, G De Rosa, AA Farooqi, A Lombardi, V Campani, ...
Molecular therapy-nucleic acids 3, e195, 2014
|BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells|
P Tassone, P Tagliaferri, A Perricelli, S Blotta, B Quaresima, ML Martelli, ...
British journal of cancer 88 (8), 1285-1291, 2003
|Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy|
P Correale, MS Rotundo, MT Del Vecchio, C Remondo, C Migali, ...
Journal of immunotherapy 33 (4), 435-441, 2010
|Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence|
MT Di Martino, E Leone, N Amodio, U Foresta, M Lionetti, MR Pitari, ...
Clinical cancer research 18 (22), 6260-6270, 2012
|Familial papillary thyroid microcarcinoma: a new clinical entity|
G Lupoli, G Vitale, M Caraglia, MR Fittipaldi, A Abbruzzese, P Tagliaferri, ...
The Lancet 353 (9153), 637-639, 1999
|Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines|
P Tassone, S Forciniti, E Galea, G Morrone, MC Turco, V Martinelli, ...
Leukemia 14 (5), 841-844, 2000
|Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro|
P Tassone, P Tagliaferri, C Viscomi, C Palmieri, M Caraglia, ...
British journal of cancer 88 (12), 1971-1978, 2003
|miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease|
M Rossi, MR Pitari, N Amodio, MT Di Martino, F Conforti, E Leone, C Botta, ...
Journal of cellular physiology 228 (7), 1506-1515, 2013
|A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: a focus on the quality of life|
F Zullo, S Palomba, T Russo, A Falbo, M Costantino, A Tolino, E Zupi, ...
American journal of obstetrics and gynecology 193 (4), 1344-1352, 2005
|Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth|
E Leone, E Morelli, MT Di Martino, N Amodio, U Foresta, A Gullą, M Rossi, ...
Clinical Cancer Research 19 (8), 2096-2106, 2013
|miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1|
N Amodio, MT Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, ...
Cell death & disease 3 (11), e436-e436, 2012
|DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma|
N Amodio, M Leotta, D Bellizzi, MT Di Martino, P D'Aquila, M Lionetti, ...
Oncotarget 3 (10), 1246, 2012
|Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial|
F Zullo, S Palomba, A Falbo, T Russo, R Mocciaro, E Tartaglia, ...
American journal of obstetrics and gynecology 200 (3), 296. e1-296. e9, 2009
|Current approaches and perspectives in the therapy of medullary thyroid carcinoma|
G Vitale, M Caraglia, A Ciccarelli, G Lupoli, A Abbruzzese, P Tagliaferri, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2001
|In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma|
MT Di Martino, A Gullą, MEG Cantafio, M Lionetti, E Leone, N Amodio, ...
Oncotarget 4 (2), 242, 2013
|Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues|
P Tagliaferri, D Katsaros, T Clair, S Ally, G Tortora, L Neckers, ...
Cancer research 48 (6), 1642-1650, 1988
|Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials|
D Ciliberto, C Botta, P Correale, M Rossi, M Caraglia, P Tassone, ...
European journal of cancer 49 (3), 593-603, 2013
|Desferioxamine increases iron depletion and apoptosis induced by ara‐C of human myeloid leukaemic cells|
A Leardi, M Caraglia, C Selleri, S Pepe, C Pizzi, R Notaro, A Fabbrocini, ...
British journal of haematology 102 (3), 746-752, 1998
|Site‐selective cyclic AMP analogs provide a new approach in the control of cancer cell growth|
D Katsaros, G Tortora, P Tagliaferri, T Clair, S Ally, L Neckers, RK Robins, ...
FEBS letters 223 (1), 97-103, 1987
|Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulation|
YS Cho-Chung, T Clair, P Tagliaferri, S Ally, D Katsaros, G Tortora, ...
Cancer Investigation 7 (2), 161-177, 1989